CME Group Inc.’s Stock Price Drops to $207.05, Marking a 1.23% Decrease

CME Group Inc. (CME)

207.05 USD -2.57 (-1.23%) Volume: 1.27M

Discover the latest on CME Group Inc.’s stock price, currently standing at 207.05 USD, experiencing a slight dip of -1.23% this trading session. With a trading volume of 1.27M, the leading and most diverse derivatives marketplace is down -1.69% YTD, highlighting its performance in the stock market.

Latest developments on CME Group Inc.

Today, CME Group Inc stock price is experiencing movements as CME and S&P Global are considering the sale of their joint venture, OSTTRA, which provides post-trade services. This news follows recent developments such as CME’s launch of a new CME Term SOFR API and analyst estimates and ratings on CME Group stock. Additionally, My Legacy Advisors LLC has taken a significant position in CME Group Inc, while there is growing influence of U.S. crude oil exports to Europe impacting the market. Traders are also keeping an eye on trading swap spreads with futures and the overview of various futures markets such as corn, Euro FX EUR/USD, and CBL Global Emissions Offset. Overall, the market is reacting positively to the potential sale of OSTTRA and other recent news surrounding CME Group Inc.

A look at CME Group Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for CME Group Inc, the company seems to have a positive long-term outlook. With high scores in Growth, Dividend, Resilience, and Momentum, CME Group Inc is positioned well for future success. The company’s strong performance in these areas indicates a promising future for investors and stakeholders.

CME Group Inc operates a derivatives exchange that trades various financial products. The company’s focus on growth, resilience, and momentum, coupled with a solid dividend offering, paints a bright picture for its future prospects. Investors may find CME Group Inc to be a favorable choice based on its overall Smartkarma Smart Scores.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma